Evidence map›Paper›PMID 38784315›Full record

ReviewCureus2024

From Alzheimer's Disease to Anxiety, Epilepsy to Schizophrenia: A Comprehensive Dive Into Neuro-Psychiatric Disorders.

Han Grezenko, Zarin Nudar Rodoshi, Ciara S Mimms, Muhammad Ahmed, Astrit Sabani, May Su Hlaing, Biniyam J Batu, Muhidin I Hundesa, Biruk D Ayalew, Abdullah Shehryar and 2 more

Abstract readReview
In one paragraph

Review in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Han GrezenkoMedicine and Surgery, Guangxi Medical University, Nanning, CHN.
Zarin Nudar RodoshiMedical Education, Mymensingh Medical College, Dhaka, BGD.
Ciara S MimmsMedicine, St. George's University, St. George's, USA.
Muhammad AhmedPsychiatry and Behavioral Sciences, Dow University of Health Sciences, Karachi, PAK.
Astrit SabaniMedicine, St. George's University, St. George's, USA.
May Su HlaingGeriatrics, United Lincolnshire Hospitals NHS Trust, Boston, GBR.
Biniyam J BatuGeneral Practice, St. Paul's Hospital Millennium Medical College, Addis Ababa, ETH.
Muhidin I HundesaMedical Services, Federal Democratic Republic of Ethiopia Ministry of Health, Addis Ababa, ETH.
Biruk D AyalewInternal Medicine, St. Paul's Hospital Millennium Medical College, Addis Ababa, ETH.
Abdullah ShehryarInternal Medicine, Allama Iqbal Medical College, Lahore, PAK.
Abdur RehmanSurgery, Mayo Hospital, Lahore, PAK.
Ahmad HassanInternal Medicine, Mayo Hospital, Lahore, PAK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This comprehensive narrative review endeavors to dissect the intricate web of neuropsychiatric disorders that significantly impact cognition, emotion regulation, behavior, and mental health. With a keen focus on Alzheimer's disease (AD), anxiety disorders, epilepsy, schizophrenia, and autism spectrum disorder (ASD), this article delves into their underlying mechanisms, clinical presentations, diagnostic challenges, and therapeutic interventions. Highlighting the considerable disability and societal costs that these conditions impose, it reflects on the over six million individuals grappling with Alzheimer's, the 19 million American adults living with anxiety disorders, the three million with epilepsy, and the global reach of schizophrenia affecting approximately 20 million people. Furthermore, it examines the emerging landscape of ASD, noting the escalating diagnosis rates and the pressing need for innovative treatments and equitable healthcare access. Through a detailed exploration of current research, technological innovations, and the promise of personalized medicine, this review aims to illuminate the complexities of these conditions, advocate for early intervention strategies, and call for a unified approach to tackling the multifaceted challenges they present. The ultimate goal is to inform and inspire healthcare professionals, researchers, and policymakers to foster advancements that improve outcomes and quality of life for individuals affected by these profound neuropsychiatric disorders, steering towards a future where these conditions are no longer insurmountable.

Indexed as

autism spectrum disorder and anxiety disorderclinical anxietydepressionepilepsyschizophrenia

Identifiers

PMID38784315
PMCPMC11112393

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.